Pacific Biosciences of California (PACB) ended the recent trading session at $1.18, demonstrating a +1.72% change from the ...

Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Pacific Biosciences of California faces steep stock decline and financial challenges. Click here to see why PACB stock is a ...

Volta Labs, a genomics applications company, today announced the launch of its Library Prep App for Oxford Nanopore LSK114 on ...

Pacific Biosciences offers advanced long-read sequencing, simplifying genome assembly and providing higher taxonomic resolution in specific research niches. While earnings were a beat, shrinking ...

A research team has identified two novel genetic mechanisms for disease resistance in wheat, offering promising strategies to ...

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences: ...

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2024 Earnings Call Transcript February 13, 2025 Pacific Biosciences of California, Inc. beats earnings expectations. Reported EPS is $0.51 ...

Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).